ライフサイエンスコーパス: subcutaneous adipose tissue

1 turnal hypoxemia predicted Angptl4 levels in subcutaneous adipose tissue.

2 sensitivity and, to a much lesser extent, in subcutaneous adipose tissue.

3 T, but not in adjoining skeletal muscles and subcutaneous adipose tissue.

4 Similar trends were observed in subcutaneous adipose tissue.

5 tion of approximately 450,000 sites in human subcutaneous adipose tissue.

6 liferator-activated receptor alpha/gamma) in subcutaneous adipose tissue.

7 h increased oxidative, but not ER, stress in subcutaneous adipose tissue.

8 insert columns of fat projecting up from the subcutaneous adipose tissue.

9 s in adipocytes isolated from epididymal and subcutaneous adipose tissue.

10 romes are characterized by extensive loss of subcutaneous adipose tissue.

11 functional differences between internal and subcutaneous adipose tissue.

12 t pads are morphologically similar to normal subcutaneous adipose tissue.

13 rtial lipodystrophy (FPLD), involves loss of subcutaneous adipose tissue.

14 characterized by the absence or reduction of subcutaneous adipose tissue.

15 inhibitors experience atrophy of peripheral subcutaneous adipose tissue.

16 the regulation of gene expression in porcine subcutaneous adipose tissue.

17 with that reported previously for abdominal subcutaneous adipose tissue.

18 change in visceral adipose tissue (VAT) and subcutaneous adipose tissue.

19 tion by increasing AKR1C3 activity in female subcutaneous adipose tissue.

20 ful visceral adipose tissue when compared to subcutaneous adipose tissue.

21 plet proteins, perilipin, and TIP47 in human subcutaneous adipose tissue.

22 old and oxidative stress decreased by 50% in subcutaneous adipose tissue.

23 accompanied by enhanced macrophage influx in subcutaneous adipose tissue.

24 g" of white fat and the healthful effects of subcutaneous adipose tissue.

25 ing and also suppressed sprouting from human subcutaneous adipose tissue.

26 tiated preadipocytes in both human and mouse subcutaneous adipose tissues.

27 n fat-like gene program and thermogenesis in subcutaneous adipose tissues.

28 e angiotensinogen gene is increased in their subcutaneous adipose tissues.

29 in the supraclavicular region) as well as in subcutaneous adipose tissues.

30 cm), lower volumes of abdominal superficial subcutaneous adipose tissue (-4.53 mL; 95% CI: -8.70, -0

31 xpressing Wnt-10b showed progressive loss of subcutaneous adipose tissue accompanied by dermal fibros

32 o adult phantoms with (E) and without (E(0)) subcutaneous adipose tissue added to the torso for five

33 nt condition characterized by marked loss of subcutaneous adipose tissue affecting the trunk and extr

34 We measured subcutaneous adipose tissue AMPK phosphorylation (threon

35 tromal cells (ASCs) were isolated from human subcutaneous adipose tissue and characterized by flow cy

36 tein lipase-derived fatty acid entrapment in subcutaneous adipose tissue and forearm muscle in health

37 taneously from an abdominal vein that drains subcutaneous adipose tissue and from a radial artery.

38 s, colon, liver, monocytes, skeletal muscle, subcutaneous adipose tissue and lymphoblastoid cell line

39 etween risk of CRC and the FA composition of subcutaneous adipose tissue and product-to-precursor rat

40 In contrast, after refeeding, total subcutaneous adipose tissue and skeletal muscle mass did

41 Ectopic Wnt-10b causes loss of subcutaneous adipose tissue and TGFbeta-independent derm

42 was to measure angiogenesis in visceral and subcutaneous adipose tissue and to establish whether the

43 ral and subcutaneous adipose tissue samples (subcutaneous adipose tissue and visceral adipose tissue)

44 ceptor antagonist), their mRNA expression in subcutaneous adipose tissue, and circulating cortisol we

45 Volumes of whole muscle, subcutaneous adipose tissue, and IMAT were assessed by u

46 PPARgamma is abundantly expressed in porcine subcutaneous adipose tissue, and that expression is regu

47 al thickness of the common carotid arteries, subcutaneous adipose tissue, and visceral adipose tissue

48 in resistance, suggesting that impairment of subcutaneous adipose tissue angiogenesis may contribute

49 s, and the expression of adipogenic genes in subcutaneous adipose tissue are linked to the phenotype

50 circumference (P = 0.012 to P = 0.023), and subcutaneous adipose tissue area (P = 0.016).

51 p = 0.001), with similar findings when using subcutaneous adipose tissue area as the adiposity measur

52 We measured the visceral adipose tissue and subcutaneous adipose tissue areas and calculated the vis

53 Visceral adipose tissue and subcutaneous adipose tissue areas were highly correlated

54 rs to quantitate visceral adipose tissue and subcutaneous adipose tissue areas.

55 agonist action were studied ex vivo on human subcutaneous adipose tissue arterioles and endothelial c

56 o compare the associations between abdominal subcutaneous adipose tissue (ASAT) and visceral abdomina

57 utaneous adipose tissue (GSAT) and abdominal subcutaneous adipose tissue (ASAT) was performed across

58 ary (P=0.03) and mesenteric (P=0.04) but not subcutaneous adipose tissue augmented coronary contracti

59 Finally, we analyzed subcutaneous adipose tissue biopsies from two independen

60 ablished cultures of these cells from paired subcutaneous adipose tissue biopsies obtained before and

61 thetic nerve fibers were measured in EAT and subcutaneous adipose tissue biopsies obtained from patie

62 ollow-up, fasted blood samples and abdominal subcutaneous adipose tissue biopsies were obtained and o

63 Abdominal subcutaneous adipose tissue biopsy samples were collecte

64 Subcutaneous adipose tissue biopsy specimens were obtain

65 ominal circumference, visceral and abdominal subcutaneous adipose tissue, blood pressure, serum lipid

66 n with clinical stage T1NO breast cancer had subcutaneous adipose tissue (breast and abdominal) aspir

67 t had similar amounts of skeletal muscle and subcutaneous adipose tissue but greater visceral adipose

68 etic resonance imaging showed an increase in subcutaneous adipose tissue but not in visceral fat.

69 Cortisol is released from subcutaneous adipose tissue by 11beta-HSD1 in humans, an

70 one of many ectopic fat depots used when the subcutaneous adipose tissue cannot accommodate excess fa

71 assessed plasma cytokine concentrations and subcutaneous adipose tissue CD4(+) T-cell populations in

72 mma1 mRNA and PPARgamma protein abundance in subcutaneous adipose tissue compared to ad-libitum fed c

73 approximately 70% reduction in visceral and subcutaneous adipose tissues compared with ob/ob mice.

74 Femoral and abdominal subcutaneous adipose tissue compartments were unaffected

75 ressed differentially between mesenteric and subcutaneous adipose tissue depots and genes previously

76 and accumulate differently in mesenteric and subcutaneous adipose tissue depots, depending on the met

77 itro effects of NO on mouse 3T3-L1 and human subcutaneous adipose tissue-derived adipocytes after a c

78 yte cultures were established from abdominal subcutaneous adipose tissue donated by healthy women und

79 se tissue (VAT)] and deep subcutaneous [deep subcutaneous adipose tissue (DSAT)] adiposity, with sign

80 The limited expandability of subcutaneous adipose tissue, due to reduced ability to r

81 ypothesis by comparing direct FFA storage in subcutaneous adipose tissue during insulin versus niacin

82 d in sympathetic innervation between EAT and subcutaneous adipose tissue, EAT showed an enhanced adre

83 function, visceral adipose tissue (VAT) and subcutaneous adipose tissue, epicardial and pericardial

84 Circulating WISP1 and WISP1 subcutaneous adipose tissue expression were regulated by

85 ese findings suggest that the propensity for subcutaneous adipose tissue FA storage is increased in p

86 exhibited coincident eQTLs (P < 1 x 10-5) in subcutaneous adipose tissue for BPTF and PDGFC.

87 We measured subcutaneous adipose tissue free fatty acid (FFA) storag

88 also obtained biopsy specimens of abdominal subcutaneous adipose tissue from 2 study participants wh

89 mRNA and activity are increased in vitro in subcutaneous adipose tissue from obese patients.

90 We assessed in vivo cellular kinetics in subcutaneous adipose tissue from the abdominal (scABD) a

91 ant disorder characterized by marked loss of subcutaneous adipose tissue from the extremities and tru

92 Using proteomics, we compared subcutaneous adipose tissues from mice in these groups a

93 Paired transcriptomic analysis of gluteal subcutaneous adipose tissue (GSAT) and abdominal subcuta

94 Subcutaneous adipose tissue had a greater angiogenic cap

95 patients with higher visceral adipose tissue/subcutaneous adipose tissue had greater 90-day mortality

96 These data imply that subcutaneous adipose tissue has a higher capacity to exp

97 viduals prone to deposit visceral instead of subcutaneous adipose tissue have higher risk of metaboli

98 condyle, calvarial bone, cranial suture, and subcutaneous adipose tissue--have been engineered from m

99 ups receiving high perinatal n-6/n-3 ratios, subcutaneous adipose tissue in 14-day-old wild-type pups

100 Subcutaneous adipose tissue in mutant mice acquired many

101 of adipocyte MCSF was then induced in rabbit subcutaneous adipose tissue in vivo using adenoviral-med

102 teric adipose tissue in Wistar lean rats but subcutaneous adipose tissue in Zucker obese rats.

103 igh ratio, waist circumference, visceral and subcutaneous adipose tissue) in well-functioning men (n

104 de, epicardial and pericardial fat, VAT, and subcutaneous adipose tissue increased stepwise from low

105 zed by a thin superficial layer of abdominal subcutaneous adipose tissue, increased visceral adipose

106 ment of functional beige fat in the inguinal subcutaneous adipose tissue (ingSAT) and perigonadal vis

107 mmation, elevated adiponectin, mulitilocular subcutaneous adipose tissue (inguinal WAT) with upregula

108 the hypothesis that the ratio of visceral to subcutaneous adipose tissue is associated with altered s

109 Finally, human subcutaneous adipose tissues isolated from obese individ

110 nogenic primary lipodystrophy-a reduction in subcutaneous adipose tissue-it is clear that it is adipo

111 These data support an important role for a subcutaneous adipose tissue-liver axis in mediating the

112 patients with lower visceral adipose tissue/subcutaneous adipose tissue (log-rank test, linear-by li

113 d that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason

114 Visceral and subcutaneous adipose tissue may contribute differentiall

115 uantitated PPARgamma mRNA splice variants in subcutaneous adipose tissue of 14 lean and 24 obese subj

116 ait locus (eQTL) analyses by using abdominal subcutaneous adipose tissue of 770 extensively phenotype

117 Expression of FSP27 in subcutaneous adipose tissue of a human diabetes cohort d

118 lso increased in epididymal, mesenteric, and subcutaneous adipose tissue of diabetic (db/db) mice and

119 containing fractions from intraabdominal and subcutaneous adipose tissue of mice revealed coordinated

120 the first demonstration of UPR activation in subcutaneous adipose tissue of obese human subjects.

121 tissue, were significantly decreased in the subcutaneous adipose tissue of obese normoglycemic and t

122 c model assessment-insulin resistance in the subcutaneous adipose tissue of obese patients.

123 learance in adipocytes freshly isolated from subcutaneous adipose tissue of obese patients.

124 eriod, whole-genome arrays were performed in subcutaneous adipose tissue of postmenopausal women (n =

125 d the in vivo effects of chronic exercise in subcutaneous adipose tissue of wild-type (WT) and endoth

126 oth PPAR gamma1 and PPAR gamma2 mRNAs in the subcutaneous adipose tissue of women compared with men.

127 chondrial DNA content, and glucose uptake in subcutaneous adipose tissue of WT but not eNOS(-/-) mice

128 ssion of most analyzed inflammatory genes in subcutaneous adipose tissue (P < 0.05) and increased pro

129 y eicosanoids in visceral adipose tissue and subcutaneous adipose tissue (P < 0.05).

130 in those with lower visceral adipose tissue/subcutaneous adipose tissue (p = 0.043).

131 Abdominal subcutaneous adipose tissue palmitate storage rates corr

132 se loci are indeed associated with abdominal subcutaneous adipose tissue parameters.

133 brocytes, which were similar to visceral and subcutaneous adipose tissue preadipocyte-to-adipocyte di

134 ted with increased heat production; however, subcutaneous adipose tissue provides an insulating layer

135 -3.99) for the third visceral adipose tissue/subcutaneous adipose tissue quartile compared with the f

136 egression, increased visceral adipose tissue/subcutaneous adipose tissue quartile was significantly a

137 .69) for the highest visceral adipose tissue/subcutaneous adipose tissue quartile when compared with

138 ients in the highest visceral adipose tissue/subcutaneous adipose tissue quartile.

139 A reduction in subcutaneous adipose tissue rather than VAT was associat

140 ectroscopy and visceral obesity (visceral-to-subcutaneous adipose tissue ratio >/=0.25) measured by m

141 8; P = 7 x 10(-8)) and increased visceral-to-subcutaneous adipose tissue ratio (beta = -0.015; P = 6

142 defined by a high visceral adipose tissue-to-subcutaneous adipose tissue ratio, contributes to advers

143 nd calculated the visceral adipose tissue-to-subcutaneous adipose tissue ratio.

144 ated with hepatic triglyceride, VAT, and VAT/subcutaneous adipose tissue ratio.

145 insulin sensitivity, and losing superficial subcutaneous adipose tissue remained neutral except for

146 - 0.5% (P < 0.0001) of FFAs were taken up by subcutaneous adipose tissue, respectively.

147 s of perigonadal, perirenal, mesenteric, and subcutaneous adipose tissue revealed that the percentage

148 cluding intraabdominal adipose tissue (IAF), subcutaneous adipose tissue (SAF), trunk fat, arm fat, a

149 inflammatory gene expression in visceral and subcutaneous adipose tissue samples (subcutaneous adipos

150 uantitative-trait-locus (eQTL) data in human subcutaneous adipose tissue samples confirmed that allel

151 Subcutaneous adipose tissue samples were collected and a

152 Paired omental and subcutaneous adipose tissue samples were obtained from 2

153 During surgery, abdominal subcutaneous adipose tissue samples were optimally colle

154 nes regulating amino acid degradation in 200 subcutaneous adipose tissue samples.

155 ammasome are linked to the downregulation of subcutaneous adipose tissue (SAT) adipogenesis/lipogenes

156 AT were related to changes in the amounts of subcutaneous adipose tissue (SAT) and visceral adipose t

157 hole- and refined-grain intake and abdominal subcutaneous adipose tissue (SAT) and visceral adipose t

158 in 3,890 nondiabetic individuals; 1,882 had subcutaneous adipose tissue (SAT) and visceral adipose t

159 Subcutaneous adipose tissue (SAT) and visceral adipose t

160 We examined the relations of abdominal subcutaneous adipose tissue (SAT) and visceral adipose t

161 We analyzed the transcriptional profiles of subcutaneous adipose tissue (SAT) and visceral adipose t

162 as an impact on gene expression in abdominal subcutaneous adipose tissue (SAT) and whether changes in

163 effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic synd

164 ies, cortical bone densities, VAT areas, and subcutaneous adipose tissue (SAT) areas at vertebral lev

165 abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) between white and Afri

166 es between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) compartments, particul

167 adipose tissue, visceral adipose tissue, and subcutaneous adipose tissue (SAT) from baseline to 6 and

168 In contrast, subcutaneous adipose tissue (SAT) growth and morphology

169 XRbeta, also repress the browning process of subcutaneous adipose tissue (SAT) in male rodents fed a

170 tor-1alpha (PPARGC1A) in skeletal muscle and subcutaneous adipose tissue (SAT) is suggested to play a

171 TSP1 gene expression was quantified in subcutaneous adipose tissue (SAT) of 86 nondiabetic subj

172 d data suggest that the effects of abdominal subcutaneous adipose tissue (SAT) on cardiovascular dise

173 Here we examined subcutaneous adipose tissue (SAT) samples from healthy m

174 VAT and subcutaneous adipose tissue (SAT) samples obtained from

175 Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) vary in volume and qua

176 y we show that ERbeta influences browning of subcutaneous adipose tissue (SAT) via its actions both o

177 Subcutaneous adipose tissue (SAT) volume, visceral adipo

178 ects of rhGH on insulin sensitivity (SI) and subcutaneous adipose tissue (SAT) volume.

179 Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) was quantified by magn

180 Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured at the L

181 densities of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intermuscular adi

182 increases in visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and intermuscular adi

183 at, visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (SAT), total adipose tissue,

184 Abdominal subcutaneous adipose tissue (SAT), visceral adipose tiss

185 ition or lipodystrophy, leading to losses of subcutaneous adipose tissue (SAT).

186 -body SM, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT).

187 We measured visceral (VAT) and subcutaneous adipose tissue (SCAT) areas at midwaist in

188 Similar relationships were found in human subcutaneous adipose tissue stained for the macrophage a

189 Subcutaneous adipose tissue stores excess lipids and mai

190 In subcutaneous adipose tissue, taurine decreased ethanol-i

191 le closely matched the fatty acid profile of subcutaneous adipose tissue TGs during epinephrine infus

192 centrations of alpha-linolenic acid in their subcutaneous adipose tissue than did controls.

193 patients with higher visceral adipose tissue/subcutaneous adipose tissue than in those with lower vis

194 expressed and secreted from visceral but not subcutaneous adipose tissue that increases insulin sensi

195 Subcutaneous adipose tissue TIMP3 expression correlated

196 OS-derived NO in the metabolic adaptation of subcutaneous adipose tissue to exercise training.

197 se was measured in the interstitial space of subcutaneous adipose tissue using microdialysis, and 39

198 ic subpopulation of cells derived from human subcutaneous adipose tissue utilizing microfluidic-based

199 weight, and volume of abdominal visceral and subcutaneous adipose tissue (VAT and SAT).

200 patients with higher visceral adipose tissue/subcutaneous adipose tissue was found for both patients

201 The ratio of visceral to subcutaneous adipose tissue was greater in both men (P <

202 Visceral adipose tissue/subcutaneous adipose tissue was not correlated with body

203 001), respectively; no significant change in subcutaneous adipose tissue was observed.

204 dermal fibrosis was observed and part of the subcutaneous adipose tissue was replaced by connective t

205 f our published dataset of 37 subjects whose subcutaneous adipose tissue was sampled before and after

206 t, the expression of inflammatory markers in subcutaneous adipose tissue was unchanged postoperativel

207 Computed tomography scans of VAT and subcutaneous adipose tissue were performed by imaging a

208 Paired samples of epicardial and subcutaneous adipose tissues were harvested at the outse

209 ating fatty acids and increased expansion of subcutaneous adipose tissue with chronic high fat diet (

210 ted with improved lipid profile, losing deep subcutaneous adipose tissue with improved insulin sensit